Consider SANCUSO for mechanically compromised patients receiving chemotherapy*

The Sancuso (Granisetron Transdermal System) patch. Not actual size.
Not actual size.
Patch is 52 cm2
(approx. 2.5 in x 3 in)
  • SANCUSO® (Granisetron Transdermal System) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration1
  • Due to its route of administration, SANCUSO may be an alternative for chemotherapy patients who are unable to take or retain oral antiemetics1,11:
    • Especially important for chemotherapy patients who have symptoms or side effects such as oral mucositis6 or dysphagia,2 those with gut motility issues,4,5 and those receiving concomitant radiation plus chemotherapy treatment3,8†

*Mechanically compromised cancer patients include those with oral and/or gastrointestinal impairment associated with chemotherapy, with or without radiation,2,3,7,8 or tumor burden, 9,10 who may be unable to take or retain oral antiemetics.11

Are your chemotherapy patients experiencing disease- or treatment-related complications that may make it difficult to take or retain oral antiemetics?

Cancer Type

Head and neck cancer12
+
TREATMENT
REGIMENS
Chemoradiation
Chemoradiation
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
Microtubule inhibitor
(paclitaxel)
Antimetabolite (5-FU)
POSSIBLE
COMPLICATIONS

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
TREATMENT
REGIMENS
POSSIBLE
COMPLICATIONS
Chemoradiation
Chemoradiation

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
Microtubule inhibitor
(paclitaxel)
Antimetabolite (5-FU)
Breast cancer13
+
TREATMENT
REGIMENS
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
Anthracycline
(doxorubicin, epirubicin)
Alkylating agent
(cyclophosphamide)
POSSIBLE
COMPLICATIONS

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
TREATMENT
REGIMENS
POSSIBLE
COMPLICATIONS
Chemotherapy
Chemotherapy

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
Platinum-based
(cisplatin, carboplatin)
Anthracycline
(doxorubicin, epirubicin)
Alkylating agent
(cyclophosphamide)
Lung cancer14
+
TREATMENT
REGIMENS
Chemoradiation
Chemoradiation
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
POSSIBLE
COMPLICATIONS

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
TREATMENT
REGIMENS
POSSIBLE
COMPLICATIONS
Chemoradiation
Chemoradiation

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
Gastrointestinal cancer15
+
TREATMENT
REGIMENS
Chemoradiation
Chemoradiation
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
Antimetabolite (5-FU)
Anthracycline
(doxorubicin, epirubicin)
TREATMENT
REGIMENS
POSSIBLE
COMPLICATIONS
Chemoradiation
Chemoradiation

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
Antimetabolite (5-FU)
Limited Gut
Motility/Absorption

Click to learn more
Anthracycline
(doxorubicin, epirubicin)
Gynecological cancer16-18
+
TREATMENT
REGIMENS
Chemoradiation
Chemoradiation
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
TREATMENT
REGIMENS
POSSIBLE
COMPLICATIONS
Chemoradiation
Chemoradiation

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)

Limited Gut
Motility/Absorption

Click to learn more
Testicular cancer19
+
TREATMENT
REGIMENS
Chemoradiation
Chemoradiation
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
POSSIBLE
COMPLICATIONS

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
TREATMENT
REGIMENS
POSSIBLE
COMPLICATIONS
Chemoradiation
Chemoradiation

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
Colorectal cancer20,21
+
TREATMENT
REGIMENS
Chemoradiation
Chemoradiation
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
Antimetabolite (5-FU)
POSSIBLE
COMPLICATIONS

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
TREATMENT
REGIMENS
POSSIBLE
COMPLICATIONS
Chemoradiation
Chemoradiation

Difficulty swallowing
(e.g. oral mucositis)
Click to learn more
Chemotherapy
Chemotherapy
Platinum-based
(cisplatin, carboplatin)
Antimetabolite (5-FU)

SANCUSO is not indicated for radiation-induced nausea and vomiting.

 

An oncologist’s perspective

Preventing chemotherapy induced nausea and vomiting (CINV) in patients who are unable to take or retain oral antiemetics

Medical oncologist Allyson Ocean, MD, discusses preventing CINV in mechanically compromised patients who are unable to take or retain oral antiemetics.*

 

When to consider SANCUSO

Are your chemotherapy patients experiencing disease- or treatment-related complications that may make it difficult to take or retain oral antiemetics?

To remind you of the mechanically compromised cancer patients for whom SANCUSO may be an alternate option


Learn the NCCN/ASCO Guidelines regarding CINV and SANCUSO